Y! Health Breast Cancer News http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/ Y! Health Breast Cancer News, updated continuously. en-us Tue, 09 Feb 2010 22:07:18 PST Copyright (c) 2010 Yahoo! Inc. All rights reserved. 5 Yahoo! Health 142 18 http://health.yahoo.com/ http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer (HealthDay)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/paxilblockstamoxifenlowerssurvivaloddsagainstbreastcancer.htmlyahoo/health/news/healthday/paxilblockstamoxifenlowerssurvivaloddsagainstbreastcancerTue, 09 Feb 2010 20:49:51 PSTHealthDay - MONDAY, Feb. 8 (HealthDay News) -- Women with breast cancer who take both tamoxifen and the antidepressant Paxil may increase their risk of dying because Paxil reduces tamoxifen's effectiveness, Canadian researchers report.Financial Woes Add Anxiety to Breast Cancer Diagnosis (HealthDay)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/financialwoesaddanxietytobreastcancerdiagnosis.htmlyahoo/health/news/healthday/financialwoesaddanxietytobreastcancerdiagnosisMon, 08 Feb 2010 20:49:35 PSTHealthDay - MONDAY, Feb. 8 (HealthDay News) -- Financial pressure puts low- and medium-income women at particularly high risk for anxiety and depression after being diagnosed with the noninvasive breast cancer ductal carcinoma in situ (DCIS), a U.S. study has found.Mood drug inhibits breast cancer medication: study (AFP)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/afp/healthdiseasecancerbreastserotonin.htmlyahoo/health/news/afp/healthdiseasecancerbreastserotoninMon, 08 Feb 2010 16:28:46 PSTAFP - A common antidepressant weakens or cancels the beneficial effects of a standard treatment for breast cancer, according to a study released Tuesday.Mood drug inhibits breast cancer medication: study (AFP)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/afp/healthdiseasecancerbreastserotonin_20100209003034.htmlyahoo/health/news/afp/healthdiseasecancerbreastserotonin_20100209003034Mon, 08 Feb 2010 16:28:46 PSTAFP - A common antidepressant weakens or cancels the beneficial effects of a standard treatment for breast cancer, according to a study released Tuesday.Popular antidepressant interferes with cancer drug (Reuters)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_cancer_breast_paxil.htmlyahoo/health/news/reuters/us_cancer_breast_paxilMon, 08 Feb 2010 16:04:12 PSTReuters - The popular antidepressant drug Paxil may interfere with breast cancer treatments, making patients more likely to relapse and die, researchers in Canada reported on Monday.Few high-risk women in U.S. take breast cancer drug (Reuters)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_breast_cancer.htmlyahoo/health/news/reuters/us_breast_cancerMon, 08 Feb 2010 14:15:29 PSTReuters - Only a small number of U.S. women at high risk of breast cancer have chosen to use the drug tamoxifen to lower that risk, according to a study published Monday.Approval Expanded for Breast Cancer Drug Tykerb (HealthDay)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/approvalexpandedforbreastcancerdrugtykerb.htmlyahoo/health/news/healthday/approvalexpandedforbreastcancerdrugtykerbMon, 01 Feb 2010 20:48:45 PSTHealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug Administration has expanded approval for Tykerb (lapatinib) to include postmenopausal women with hormone- and HER2-positive advanced breast cancer who require hormone therapy.Herceptin Again Proves Mettle Against Breast Cancer (HealthDay)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/herceptinagainprovesmettleagainstbreastcancer.htmlyahoo/health/news/healthday/herceptinagainprovesmettleagainstbreastcancerFri, 29 Jan 2010 20:49:20 PSTHealthDay - THURSDAY, Jan. 28 (HealthDay News) -- High-risk breast cancer patients with HER2-positive tumors benefit from receiving the targeted therapy Herceptin while undergoing chemotherapy, new research shows.Mammograms may be overused in women with dementia (Reuters)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_mammograms.htmlyahoo/health/news/reuters/us_mammogramsFri, 29 Jan 2010 12:52:33 PSTReuters - Some elderly women with severe cognitive impairment are getting mammography breast cancer screening even though they are unlikely to ever benefit from it, a new study finds.Gene discovery may help guide breast cancer care (Reuters)http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/us_cancer_breast_test.htmlyahoo/health/news/reuters/us_cancer_breast_testSun, 24 Jan 2010 10:03:34 PSTReuters - An abnormality in two genes can make a common class of chemotherapy drugs used to fight breast cancer less effective, U.S. researchers said on Sunday in a finding that could help doctors better tailor treatments.